Malawi and Tanzania launch national "provided-initiated" HIV screening:
This article was originally published in Clinica
Executive Summary
The government of Malawi is calling on the sexually-active of its population to test for HIV. The move is in response to an acknowledged lack of control of the disease and a need for better data to support prevention planning. Estimates put national prevalence at around 14% of the country's 12 million population; only 15% of the country's six million sexually-active population are thought to know their HIV status. The programme will also adopt guidance issued recently by the WHO on conducting "provider-initiated" voluntary testing, from which the patient has to actively opt out (see Clinica No 1259, p 9). Around 80% of people with HIV in sub-Saharan Africa are unaware of being infected, the WHO estimates. Tanzania, too, has just launched a national HIV-testing programme based on this guidance, Clinica understands.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.